Liver Cirrhoses Clinical Trial
Official title:
Early Use of Transjugular Intrahepatic Portosystemic Shunt(TIPS)With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites
This multicenter RCT is designed to investigate if TIPS with covered stents improves transplant-free survival for cirrhotic patients with early stage of refractory ascites compared to LVP+albumin during 1 year follow-up period.
Status | Recruiting |
Enrollment | 180 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Confirmed diagnosis of liver cirrhosis - Recurrent and refractory ascites - Patients with an age between 18 and 65 years old - Child-Pugh =12 - Absence of hepatic encephalopathy - Patient is willing and able to comply with all study protocol requirements, including specified follow-up and testing. - Patient, or legal authorized representative, is willing to provide written informed consent prior to enrollment in the study Exclusion Criteria: - With more than 6 paracenteses within the last 3 months - patients expected to receive transplants within the next 6 months or on waiting list - Usual contra-indication for TIPS: congestive heart failure NYHA>III or medical history of pulmonary hypertension, portal vein thrombosis(>50%), hepatic polycystosis, intra-hepatic bile ducts dilatation - Patient has had previous TIPS placement - Severe liver dysfunction by: Prothrombin index < 40% or total bilirubin > 50µmol/l - Serum creatinine >133µmol/l - Severe hyponatremia <125mmol / L - Uncontrolled sepsis - Gastrointestinal hemorrhage within 6 weeks of randomization - Known allergy to albumin - Pregnant or breast feeding women - Refusal to participate or patient unable to receive informations or to sign written informed consent |
Country | Name | City | State |
---|---|---|---|
China | the First Affiliated Hospital, Air Force Medical University | Xi'an | Shaanxi |
China | Xi'an International Medical Center Hospital | Xi'an | Shaanxi |
Lead Sponsor | Collaborator |
---|---|
Air Force Military Medical University, China |
China,
Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014 Mar 14;20(10):2704-14. doi: 10.3748/wjg.v20.i10.2704. Review. — View Citation
Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, Mathurin P, Otal P, Cabarrou P, Péron JM, Vinel JP. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology. 2017 Jan;152(1):157-163. doi: 10.1053/j.gastro.2016.09.016. Epub 2016 Sep 20. Erratum in: Gastroenterology. 2017 Sep;153(3):870. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Transplant-free survival | 12 months | ||
Secondary | Frequency of paracentesis | 12 months | ||
Secondary | Frequency of overt Hepatic Encephalopathy | Number of episodes of West Haven grade 2 or greater without precipitating factor | 12 months | |
Secondary | Nutritional status | 12 months | ||
Secondary | Quality of life | 12 months | ||
Secondary | Other Liver Disease Complications (Adverse Events) | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03219372 -
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
|
Phase 2 | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Recruiting |
NCT04057287 -
Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)
|
||
Recruiting |
NCT04089878 -
"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt
|
N/A | |
Completed |
NCT04212286 -
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
|
N/A | |
Completed |
NCT04474743 -
Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study
|
||
Recruiting |
NCT03694691 -
Developing Viability Index for Machine Perfused Livers
|
N/A | |
Terminated |
NCT04072601 -
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
|
Phase 4 | |
Terminated |
NCT03878563 -
Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC)
|
||
Terminated |
NCT04160039 -
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit
|
N/A | |
Recruiting |
NCT04191369 -
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.
|
N/A | |
Completed |
NCT03083925 -
Viatorr CX Case-control Study for Complications of Portal Hypertension
|
||
Not yet recruiting |
NCT03855709 -
Antibiotic-resistant Bacterial Infection of Hepatic Patients
|
||
Recruiting |
NCT02484573 -
Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)
|
N/A | |
Recruiting |
NCT04357600 -
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
|
Phase 1/Phase 2 | |
Completed |
NCT03156426 -
Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis
|
||
Active, not recruiting |
NCT03868397 -
Preoperative Portal and Splanchnic Flow Measurement Using MRI
|
N/A | |
Terminated |
NCT03650660 -
Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist
|
||
Completed |
NCT03871894 -
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
|
N/A | |
Completed |
NCT03283176 -
Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin
|